Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Better Family Plan

Staff  |  Issue: October 2007  |  October 1, 2007

All women contemplating pregnancy should take a pre-natal multivitamin prior to conception. Women who have taken methotrexate or sulfasalazine may be folate deficient, and therefore in particular need of extra folic acid prior to pregnancy.

Low-dose aspirin has been studied extensively in pregnancy, primarily as a preventive measure against preeclampsia. In a Cochrane Collaboration report of more than 20 such studies, the risk of preeclampsia, preterm birth, and fetal demise were all modestly – but significantly – decreased.15 The Cochrane report recommends that all women at high risk for preeclampsia consider taking a low dose of aspirin throughout pregnancy. Aspirin at this dose has proven safe and does not increase congenital abnormalities in the offspring. In studies of SLE pregnancies, preeclampsia may occur in 10% to 25% of all pregnancies, compared with 5% to 10% of healthy pregnancies.7,16 For this reason, it may be argued that all women with SLE should take a low-dose aspirin throughout pregnancy.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The maintenance of normal blood pressure is important throughout pregnancy. Women with hypertension in the first trimester have a several-fold increased risk for pregnancy loss.12 In the Hopkins Lupus Cohort, this risk was eliminated by the maintenance of normal blood pressure with anti-hypertensive medication. Most obstetricians prefer to avoid ACE inhibitors and diuretics during pregnancy. For this reason, modification of a woman’s anti-hypertensive regimen may be required – preferably prior to conception.

Hydroxychloroquine is considered safe during pregnancy. More than 300 pregnancies in patients on this drug have been reported, with no increased risk for congenital abnormalities identified. Ophthalmologic and cardiac abnormalities have not been identified in offspring after systematic exams.17 Further, in the Hopkins Lupus Cohort, there was an increase in lupus activity during pregnancy among women who discontinued hydroxychloroquine early in pregnancy.18 These women had more arthritis and cutaneous disease and required higher doses of corticosteroids to control their disease during pregnancy. Based on this data, I recommend that all women continue hydroxychloroquine ≤400 mg per day throughout pregnancy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Azathioprine may be the safest immunosuppressant in pregnancy. There are extensive reports of pregnancies exposed to azathioprine among women with kidney transplantation or inflammatory bowel disease.19 These studies did not find an increased risk for congenital abnormalities among infants exposed in utero to azathioprine. They did find, however, an increased rate of preterm births after azathioprine exposure. It is unclear if this was caused by the drug or the underlying disease it was used to treat.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Diagnostic CriteriaPathogenesispregnancySLEsystemic lupus erythematosus (SLE)systemic lupus erythematous

Related Articles

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

    Challenges in Reproductive Health in Rheumatic Disease

    July 11, 2022

    In light of new challenges to individuals’ reproductive rights and the known challenges of clinical management of rheumatic disease patients during pregnancy, we review the current state of reproductive rheumatology and the management of patients with rheumatic disease during pregnancy.

    Treat to Target: Rheumatoid Arthritis in Pregnant Patients

    October 1, 2012

    A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

    AndreyCherkasov / Shutterstock.com

    Rheumatic Disease Does Not Preclude Pregnancy

    November 9, 2017

    Preconception planning is essential to help women with autoimmune disease have optimal pregnancy outcomes. Unplanned pregnancy can also negatively impact disease course in some patients. Yet many rheumatologic patients of childbearing age do not receive adequate contraception or prepregnancy education and counseling. Rheumatologists must work collaboratively with other healthcare providers to make sure rheumatic patients…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences